SEC Form 4 · accession 0001209191-15-083803
NEKTAR THERAPEUTICS · NKTR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher A Kuebler
Director
Period of report
Dec 4, 2015
Accepted (ET)
Dec 7, 2015 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000906709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 4, 2015 | M | 15,000 | $5.15 | A | 35,000 | D | |
| Common StockF1 | Dec 4, 2015 | S | 15,000 | $15.82 | D | 20,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $5.15 | Dec 4, 2015 | M | 15,000 | D | Dec 1, 2009 | Dec 1, 2016 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1This transaction involved a stock option scheduled to expire in 2016.